MARKSANS PHARMA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 262.92 INR | +1.76% |
|
+8.50% | +63.30% |
| Aug. 21 | Marksans Pharma Arm Gets UK Regulator's Marketing Nod for Fluoxetine Capsules | MT |
| Aug. 20 | Marksans Pharma Gets US FDA's EIR for Goa, India Unit | MT |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 3 | |||||||||
| 25 | |||||||||
| 25 | |||||||||
| 22 | |||||||||
| 27 | |||||||||
| 26 | |||||||||
| 19 | |||||||||
| 20 | |||||||||
| 21 | |||||||||
| 24 | |||||||||
| 22 | |||||||||
| 22 | |||||||||
| 21 | |||||||||
| 27 | |||||||||
| 21 | |||||||||
| 15 | |||||||||
| 16 | |||||||||
| 18 | |||||||||
| 17 | |||||||||
| Average | 21 | ||||||||
| Weighted average by Cap. | 23 |
- Stock Market
- Equities
- MARKSANS Stock
- Sector Marksans Pharma Limited
- Sector revisions